The bibliographic data submitted provide evidence to support the indications: • Treatment of NSAID-associated benign gastric and duodenal ulcers in patients requiring continuous NSAID-treatment” • Prophylaxis of NSAID-associated benign gastric and duodenal ulcers patients at risk requiring continuous NSAID-treatment”.